НовостиBenzingaMorgan Stanley Maintains Overweight on Attovia Therapeutics, Raises Price Target to $40 Morgan Stanley Maintains Overweight on Attovia Therapeutics, Raises Price Target to $40 Benzinga 2026.11.10 17:00 (GMT+0) Открыть на Benzinga Другие новости